Analyst Ratings for MAKO Surgical (MAKO)
MAKO Rating Summary
MAKO Price Target Summary
- Highest: $50.00 (Piper Jaffray)
- Lowest: $12.00 (WallachBeth Capital)
- Average: $22.78
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$22.78 (+101.8%)
Avg. $ Target:
$22.78 (+101.8%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/22/2013 | WallachBeth Capital | New Coverage | Hold (N/A) |
12.00 (N/A) |
10.73 | 11.29 | 5.22% | Details |
| 4/9/2013 | Mizuho Securities | Upgrade | Buy (Neutral) |
14.00 (12.00) |
10.58 | 11.29 | 6.71% | Details |
| 11/5/2012 | Summer Street | Upgrade | Buy (Neutral) |
N/A (N/A) |
15.40 | 11.29 | -26.69% | Details |
| 9/5/2012 | Wells Fargo | New Coverage | Market Perform (N/A) |
17.00 (N/A) |
16.04 | 11.29 | -29.61% | Details |
| 8/30/2012 | Dougherty & Co | Downgrade | Neutral (Buy) |
N/A (N/A) |
17.27 | 11.29 | -34.63% | Details |
| 7/10/2012 | Goldman Sachs » Updated 11/14/2012 |
Downgrade | Neutral (Buy) |
16.00 (17.00) |
15.05 | 11.29 | -24.98% | Details |
| 6/7/2012 | William Blair | Upgrade | Outperform (Market Perform) |
N/A (N/A) |
23.15 | 11.29 | -51.23% | Details |
| 4/13/2012 | Oppenheimer » Updated 2/27/2013 |
New Coverage | Perform (N/A) |
13.00 (14.00) |
41.56 | 11.29 | -72.83% | Details |
| 7/11/2011 | Morgan Stanley | New Coverage | Equalweight (N/A) |
N/A (N/A) |
32.75 | 11.29 | -65.53% | Details |
| 6/14/2011 | Canaccord Genuity » Updated 11/8/2012 |
New Coverage | Hold (N/A) |
26.00 (24.00) |
29.85 | 11.29 | -62.18% | Details |
| 1/3/2011 | JPMorgan » Updated 9/20/2012 |
Downgrade | Neutral (N/A) |
20.00 (17.00) |
15.22 | 11.29 | -25.82% | Details |
| 12/16/2010 | BioLogic Equity Research | Downgrade | Sell (N/A) |
N/A (N/A) |
15.41 | 11.29 | -26.74% | Details |
| 9/21/2010 | Brigantine Advisors » Updated 3/2/2011 |
New Coverage | Buy (N/A) |
N/A (N/A) |
10.13 | 11.29 | 11.45% | Details |
